CLINICAL_TRIALS
trial_result
· 2019-06-26
Clinical Trial Update: Comparison of CHS-0214 to Enbrel (Etanercept) in Patients With Rheumatoid Arthritis (RA) [Phase 3]
Summary
A Phase 3 trial comparing CHS-0214 to Enbrel (Etanercept) in rheumatoid arthritis has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Coherus Oncology, Inc. | Conditions: Rheumatoid Arthritis | Phase 3 | Status: COMPLETED | Results posted: 2019-06-26